Literature DB >> 30023397

Unmask the genetic backbone of ibrutinib-relapsed chronic lymphocytic leukemia progression and Richter transformation.

Wei-Ge Wang1,2, Xiao-Yan Zhou1,2, Xiao-Qiu Li1,2.   

Abstract

Entities:  

Year:  2018        PMID: 30023397      PMCID: PMC6035973          DOI: 10.21037/atm.2018.05.34

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  8 in total

1.  Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance.

Authors:  Rosella Famà; Riccardo Bomben; Silvia Rasi; Michele Dal Bo; Carmela Ciardullo; Sara Monti; Francesca Rossi; Tiziana D'Agaro; Antonella Zucchetto; Valter Gattei; Gianluca Gaidano; Davide Rossi
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 2.  Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.

Authors:  Shuang Q Zhang; Sonali M Smith; Shuang Y Zhang; Yue Lynn Wang
Journal:  Br J Haematol       Date:  2015-04-09       Impact factor: 6.998

3.  Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

Authors:  Jennifer A Woyach; Richard R Furman; Ta-Ming Liu; Hatice Gulcin Ozer; Marc Zapatka; Amy S Ruppert; Ling Xue; Daniel Hsieh-Hsin Li; Susanne M Steggerda; Matthias Versele; Sandeep S Dave; Jenny Zhang; Ayse Selen Yilmaz; Samantha M Jaglowski; Kristie A Blum; Arletta Lozanski; Gerard Lozanski; Danelle F James; Jacqueline C Barrientos; Peter Lichter; Stephan Stilgenbauer; Joseph J Buggy; Betty Y Chang; Amy J Johnson; John C Byrd
Journal:  N Engl J Med       Date:  2014-05-28       Impact factor: 91.245

4.  Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.

Authors:  Sabah Kadri; Jimmy Lee; Carrie Fitzpatrick; Natalie Galanina; Madina Sukhanova; Girish Venkataraman; Shruti Sharma; Brad Long; Kristin Petras; Megan Theissen; Mei Ming; Yuri Kobzev; Wenjun Kang; Ailin Guo; Weige Wang; Nifang Niu; Howard Weiner; Michael Thirman; Wendy Stock; Sonali M Smith; Chadi Nabhan; Jeremy P Segal; Pin Lu; Y Lynn Wang
Journal:  Blood Adv       Date:  2017-05-02

5.  Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Jan A Burger; Kristie A Blum; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Yun Shaw; Elizabeth Bilotti; Cathy Zhou; Danelle F James; Susan O'Brien
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

6.  Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.

Authors:  Kami J Maddocks; Amy S Ruppert; Gerard Lozanski; Nyla A Heerema; Weiqiang Zhao; Lynne Abruzzo; Arletta Lozanski; Melanie Davis; Amber Gordon; Lisa L Smith; Rose Mantel; Jeffrey A Jones; Joseph M Flynn; Samantha M Jaglowski; Leslie A Andritsos; Farrukh Awan; Kristie A Blum; Michael R Grever; Amy J Johnson; John C Byrd; Jennifer A Woyach
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

7.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245

8.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.